Arix Bioscience (LON:ARIX) Hits New 52-Week Low at $135.00

Arix Bioscience plc (LON:ARIX)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as GBX 135 ($1.76) and last traded at GBX 135 ($1.76), with a volume of 137361 shares changing hands. The stock had previously closed at GBX 137.50 ($1.80).

Separately, Shore Capital restated a “hold” rating on shares of Arix Bioscience in a research report on Thursday, August 12th.

The stock has a 50-day moving average of GBX 148.20. The stock has a market cap of £174.46 million and a PE ratio of 4.91. The company has a debt-to-equity ratio of 0.05, a quick ratio of 74.86 and a current ratio of 75.64.

Arix Bioscience Company Profile (LON:ARIX)

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences.

Featured Story: How to start trading in the forex market?

Receive News & Ratings for Arix Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arix Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.